Expression of the p53 homologue p630α and ΔNp63α in normal and neoplastic cells

被引:69
作者
Hall, PA [1 ]
Campbell, SJ [1 ]
O'Neill, M [1 ]
Royston, DJ [1 ]
Nylander, K [1 ]
Carey, FA [1 ]
Kernohan, NM [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland
关键词
D O I
10.1093/carcin/21.2.153
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
A burgeoning family of p53-related genes have been described recently, including p73 and p63, Both these genes encode proteins with many similarities to p53 but also with the potential for forming a range of related species by alternative promoter usage and alternative splicing. In order to begin the characterization of p63, we generated a polyclonal serum (designated SC1) that recognizes the C-terminus of p63 alpha. We have shown that this reagent recognizes p63 alpha but not p53 nor p73, By western blot analysis both p63 alpha and the N-terminal truncated form of p63 alpha (Delta Np63 alpha) were found in a range of cell lines. Similar immunoblot analysis of tissues reveals considerable complexity with at least four SC1-immunoreactive isoforms being identified. In immunohistological studies SC1 immunoreactivity is widely detectable, being predominantly associated with proliferative compartments in epithelia. However, non-proliferative populations can also show SC1 immunostaining, No simple relationship between the isoforms identified by immunoblotting of tissue lysates and the tissue immunostaining characteristics was identified. A previously unrecognized species intermediate in mobility between p63 alpha and Delta Np63 alpha was found in several tissues, including nerve and peripheral blood lymphocytes, Interestingly, there is suppression of p63 alpha expression in HaCat cells in a time- and concentration-dependent manner after UV and MMS treatment. Our data provide further information about the complexity of p63 and the SC1 serum will prove to be a useful tool in further studies of this p53 homologue.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 53 条
[1]
Agami R, 1999, NATURE, V399, P809
[2]
The p53 network [J].
Agarwal, ML ;
Taylor, WR ;
Chernov, MV ;
Chernova, OB ;
Stark, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :1-4
[3]
The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells [J].
Almog, N ;
Li, RZ ;
Peled, A ;
Schwartz, D ;
Wolkowicz, R ;
Goldfinger, N ;
Pei, HP ;
Rotter, V .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (02) :713-722
[4]
IMMUNOLOGICALLY DISTINCT P53 MOLECULES GENERATED BY ALTERNATIVE SPLICING [J].
ARAI, N ;
NOMURA, D ;
YOKOTA, K ;
WOLF, D ;
BRILL, E ;
SHOHAT, O ;
ROTTER, V .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (09) :3232-3239
[5]
NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[6]
Further characterisation of the p53 responsive element - Identification of new candidate genes for trans-activation by p53 [J].
Bourdon, JC ;
DeguinChambon, V ;
Lelong, JC ;
Dessen, P ;
May, P ;
Debuire, B ;
May, E .
ONCOGENE, 1997, 14 (01) :85-94
[7]
The challenge of p53: Linking biochemistry, biology, and patient management [J].
Bray, SE ;
Schorl, C ;
Hall, PA .
STEM CELLS, 1998, 16 (04) :248-260
[8]
CHILOSI M, 1987, AM J PATHOL, V128, P464
[9]
THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS [J].
CLARKE, AR ;
PURDIE, CA ;
HARRISON, DJ ;
MORRIS, RG ;
BIRD, CC ;
HOOPER, ML ;
WYLLIE, AH .
NATURE, 1993, 362 (6423) :849-852
[10]
Two new p73 splice variants, γ and δ, with different transcriptional activity [J].
De Laurenzi, V ;
Costanzo, A ;
Barcaroli, D ;
Terrinoni, A ;
Falco, M ;
Annicchiarico-Petruzzeli, M ;
Levrero, M ;
Melino, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1763-1768